Benzonatate Capsule
Product Images NDC 64980-635

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 64980-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benzo-cap-100mg (Benzo Cap 100mg)

This is a description of Benzonatate Capsules, a medication containing 100mg of Benzonatate USP per soft gelatin capsule. It is recommended to protect from light, keep tightly closed, and store between 20-25°C (68-77°F). The capsules should be swallowed whole and not broken, chewed, dissolved, cut, or crushed. Manufactured by CSPC-NEP Pharmaceutical Co.Ltd in Hebei, China, and distributed by Rising Pharma Holdings in East Brunswick. The usual dosage and full prescribing information can be found in the package insert.*

FDA Label Image

Benzo-cap-200mg (Benzo Cap 200mg)

This is information about Benzonatate Capsules. Each soft gelatin capsule contains 200 mg of Benzonatate, USP. It is recommended to protect the capsules from light and keep them tightly closed. The usual dosage instructions can be found in the package insert. The capsules should be stored between 20°C to 25°C. Patients are advised to swallow the capsules whole and not break, chew, dissolve, cut, or crush them. The manufacturer is CSPC-NEP Pharmaceutical Co. Ltd in China, and the distributor is Rising Pharma Holdings, Inc. This information was last issued in 2024.*

FDA Label Image

Chemical Structure (Benzonatate 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.